Journal of Hepatology
Volume 48, Issue 5 , Pages 721-727 , May 2008

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C

  • Manuel Romero-Gómez

      Affiliations

    • Unit for the Clinical Management of Digestive Diseases and CIBEREHD, Hospital Universitario de Valme, Seville, Spain
    • Corresponding Author InformationCorresponding author. Tel.: +34 955 01 57 69; fax: +34 955 01 58 85.
    • ,
  • Conrado M. Fernández-Rodríguez

      Affiliations

    • Gastroenterology Unit, Fundación Hospital Alcorcón, Madrid, Spain
    • ,
  • Raúl J. Andrade

      Affiliations

    • Hepatology Unit, Hospital Universitario Virgen de la Victoria, Malaga, Spain
    • ,
  • Moisés Diago

      Affiliations

    • Hepatology Unit, Hospital General de Valencia, Valencia, Spain
    • ,
  • Sonia Alonso

      Affiliations

    • Gastroenterology Unit, Fundación Hospital Alcorcón, Madrid, Spain
    • ,
  • Ramón Planas

      Affiliations

    • Hepatology Unit, Hospital Germans Trias i Pujol, Barcelona, Spain
    • ,
  • Ricard Solá

      Affiliations

    • Hepatology Section, Hospital del Mar, Barcelona, Spain
    • ,
  • José A. Pons

      Affiliations

    • Hepatology Section, Hospital Arrixaca, Murcia, Spain
    • ,
  • Javier Salmerón

      Affiliations

    • Digestive Unit, Hospital San Cecilio, Granada, Spain
    • ,
  • Rafael Barcena

      Affiliations

    • Hepatology Unit, Hospital Ramón y Cajal, Madrid, Spain
    • ,
  • Ramón Perez

      Affiliations

    • Digestive Unit, Hospital Central de Asturias, Oviedo, Spain
    • ,
  • Isabel Carmona

      Affiliations

    • Digestive Departament, Hospital Virgen Macarena, Seville, Spain
    • ,
  • Santiago Durán

      Affiliations

    • Endocrinology Unit, Hospital Universitario de Valme, Seville, Spain

Received 25 September 2007 ,Revised 25 October 2007 ,Accepted 1 November 2007.

References 

  1. Romero-Gómez M. Hepatitis C and insulin resistance. WJG. 2006;12:7075–7080
  2. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care. 2006;295:1096–1101
  3. Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Tsukamoto K, Kimura S, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology. 2004;126:840–848
  4. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, Salmeron J, Diago M, Fernandez-Rodriguez CM, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology. 2005;128:636–641
  5. Lecube A, Hernandez C, Genesca J, Simo R. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care. 2006;29:1140–1149
  6. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med. 2000;133:592–599
  7. Knobler H, Zhornicky T, Sandler A, Haran N, Ashur Y, Schattner A. Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol. 2003;98:2751–2756
  8. Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol. 2004;165:1499–1508
  9. Mehta SH, Bracanti FL, Strathdee SA, Pankow JS, Netski D, Coresh J, et al. Hepatitis C infection and incident type 2 diabetes. Hepatology. 2003;38:50–56
  10. Simo R, Lecube A, Genesca J, Esteban JI, Hernandez C. Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection. Diabetes Care. 2006;29:2462–2466
  11. Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S, et al. Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2. Am J Gastroenterol. 2007;102:570–576
  12. Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol. 2003;158:1154–1160
  13. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology. 2003;125:1695–1704
  14. Pazienza V, Clement S, Pugnale P, Conzelman S, Foti M, Mangia A, et al. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology. 2007;45:1164–1171
  15. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol. 2001;35:279–283
  16. Kruszynska YT, Home PD, McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology. 1991;14:103–111
  17. Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J Hepatol. 2004;41:132–138
  18. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005;28:S37–S42.
  19. Kim SH, Chunawala L, Linde R, Reaven GM. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice. J Am Coll Cardiol. 2006;48:293–297
  20. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Bittner V, Cauley JA, et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med. 2005;142:813–820
  21. Forouhi NG, Balkau B, Borch-Johnsen K, Dekker J, Glumer C, Qiao Q, et al. The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group (EDEG). Diabetologia. 2006;49:822–827
  22. Romero-Gomez M, Castellano-Megias VM, Grande L, Irles JA, Cruz M, Nogales MC, et al. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Am J Gastroenterol. 2003;98:1135–1141
  23. Lecube A, Hernandez C, Genesca J, Esteban JI, Jardi R, Simo R. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care. 2004;27:1171–1175
  24. Zein CO, Levy C, Basu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol. 2005;100:48–55
  25. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 1994;308:1323–1328
  26. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetes Med. 2002;19:708–723

☆ The authors who have taken part in the research of this paper declared that they do not have a relationship with the manufacturers of the drug involved either in the past or present and they did not receive funding from the manufacturers to carry out their research. They did not receive funding from any source to carry out this study.

PII: S0168-8278(08)00010-X

doi: 10.1016/j.jhep.2007.11.022

Journal of Hepatology
Volume 48, Issue 5 , Pages 721-727 , May 2008

Article Tools

* Image Usage & Resolution